* Note: Prices are in Million (M) USD.
Description:
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $534 M
Debt : $0 M
EBITDA : $4,378 M
Since Cash is greater than Total Debt, 5 points assigned.
This criteria used industry in which company operates:
Sector: Healthcare
Industry: Medical devices
Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 32.73
Since Forward PE Ratio is between 25 - 35, 1 point assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Using last 20 overlapping fiscal years (max 20).Average Free Cash Flow: $937 M
Average Revenue: $9,342 M
Revenue Converted To Free Cash Flow (%): 10.0%
Since Free Cash Flow (FCF) to Revenue percentage is less than 15, 1 point assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $16,747 M
Revenue 4 Years Ago (2020-12-31): $9,913 M
Last 5 Years Average Revenue Growth: 14%
Since Revenue Growth is between 10 - 15, 3 points assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-12-31): $1,486 M
Share Count 5 Years Ago (2020-12-31): $1,417 M
Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Next Year Earnings Per Share (EPS): $3.45
Trailing 12-Month Earnings Per Share (EPS): $2.98
Average Earnings Per Share (EPS): $3.22
Dividend Per Share (DPS): $0
Payout Ratio: 0%
Dividend Yield: 0%
Since Dividend Per Share is less than or equal to 0, 0 point assigned.
Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Using last 20 valid ROE years (max 20).Average ROE: -1.1%
Since Average ROE is non-positive, 0 point assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $105
52-Week Low: $78
Threshold Price (15% Above 52-Week Low): $89
Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $152,872 M
Since Market Cap is between 100B - 500B, 3 points assigned.
% Exposure to Total Portfolio
Based on the market cap, we recommend do not exceed 4% exposure of Total Portfolio.
Value-Trade has assigned 16 points to above Boston Scientific Corp (BSX) stock.
Last 20 Years Avg PE
22.39, Fair Value PE
12, Industry Based PE
18, Growth Based PE
13.79, RCFC Based PE
10.03, Risk-Free Anchored PE (25% MoS)
17.61. Based on these 6 values, average assigned is
15.64. Value-Trades has assined P/E value
15.64. An average (Current Year EPS + Next Year EPS) earning per share is
$3.215.
Fair value using multiple P/Es (blended): $50.27 (PE 15.64 × EPS $3.22)
So the Final Fair Value is: $50.27
